Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 04, 2012 09:00 ET | Source: Momenta Pharmaceuticals

Momenta Pharmaceuticals Announces Presentation of Data Supporting Clinical Development of Novel Oncology Drug Candidate M402

CHICAGO, June 4, 2012 (GLOBE NEWSWIRE) -- Preclinical data for M402, a novel oncology drug candidate being developed by Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), showed that M402 in combination...
May 30, 2012 08:30 ET | Source: Momenta Pharmaceuticals

Momenta to Present at the Goldman Sachs 33rd Annual Global Healthcare Conference

CAMBRIDGE, Mass., May 30, 2012 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
May 11, 2012 08:00 ET | Source: Momenta Pharmaceuticals

Momenta to Present at the Bank of America Merrill Lynch 2012 Health Care Conference

CAMBRIDGE, Mass., May 11, 2012 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
May 03, 2012 08:00 ET | Source: Momenta Pharmaceuticals

Momenta Pharmaceuticals Reports First Quarter 2012 Financial Results

CAMBRIDGE, Mass., May 3, 2012 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
April 20, 2012 08:30 ET | Source: Momenta Pharmaceuticals

Momenta Pharmaceuticals Announces Date of First Quarter 2012 Financial Results Conference Call

CAMBRIDGE, Mass., April 20, 2012 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, will...
March 12, 2012 12:30 ET | Source: Momenta Pharmaceuticals

Momenta to Present at the Barclays Capital Global Healthcare Conference

CAMBRIDGE, Mass., March 12, 2012 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
March 02, 2012 15:30 ET | Source: Momenta Pharmaceuticals

Momenta to Present at the Cowen and Company 32nd Annual Health Care Conference

CAMBRIDGE, Mass., March 2, 2012 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
February 24, 2012 16:30 ET | Source: Momenta Pharmaceuticals

Momenta to Present at the 2012 Citi Global Health Care Conference

CAMBRIDGE, Mass., Feb. 24, 2012 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
February 13, 2012 17:00 ET | Source: Momenta Pharmaceuticals

Momenta to Present at the Leerink Swann 2012 Global Healthcare Conference

CAMBRIDGE, Mass., Feb. 13, 2012 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
February 09, 2012 08:30 ET | Source: Momenta Pharmaceuticals

Momenta Pharmaceuticals Reports Financial Results for the Fourth Quarter and Year End 2011

CAMBRIDGE, Mass., Feb. 9, 2012 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...